The goal of the proposed study is to evaluate the efficacy and safety of silymarin in
individuals with gambling disorder. The hypothesis to be tested is that silymarin will be
more effective and well tolerated in subjects with gambling disorder compared to placebo. The
proposed study will provide needed data on the treatment of a disabling disorder that
currently lacks a clearly effective treatment.